These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 902682)
1. Genetic variation in antibody response and natural killer cell activity against a Moloney virus-induced lymphoma (YAC). Asjö B; Kiessling R; Klein G; Povey S Eur J Immunol; 1977 Aug; 7(8):554-8. PubMed ID: 902682 [TBL] [Abstract][Full Text] [Related]
2. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection. Jiang D; Flyer DC J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885 [TBL] [Abstract][Full Text] [Related]
3. Genetic control of sensitivity to Moloney leukemia virus in mice. III. The three H-2 linked Rmv genes are immune response genes controlling the antiviral antibody response. Debré P; Boyer B; Gisselbrecht S; Bismuth A; Lévy JP Eur J Immunol; 1980 Dec; 10(12):914-8. PubMed ID: 6781910 [TBL] [Abstract][Full Text] [Related]
4. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor. Hackett J; Bennett M; Kumar V J Immunol; 1985 Jun; 134(6):3731-8. PubMed ID: 3989295 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the allospecific and viral-specific immune responses to irradiated versus formaldehyde-fixed allogeneic Moloney lymphoma cells in CBA mice. Lamon EW; Gatti RA; Kiessling R; Fenyö EM Cancer Res; 1975 Apr; 35(4):962-9. PubMed ID: 1090367 [TBL] [Abstract][Full Text] [Related]
6. Naturally occurring leukemia viruses in H-2 congenic C57BL mice. II. Antibody response to viral envelope antigens. Vlug A; Melief CJ; de Bruyne C; Schoenmakers H; Molenaar JL J Natl Cancer Inst; 1980 May; 64(5):1191-8. PubMed ID: 6245302 [TBL] [Abstract][Full Text] [Related]
7. Assessment of reactivities of natural antibodies to endogenous RNA tumor virus envelope antigens and virus-induced cell surface antigens. Hanna MG; Ihle JN; Batzing BL; Tennant TW; Schenley CK Cancer Res; 1975 Jan; 35(1):164-71. PubMed ID: 45890 [TBL] [Abstract][Full Text] [Related]
8. Variants from a MLV-induced lymphoma selected for decreased sensitivity to NK lysis. Grönberg A; Kiessling R; Eriksson E; Hansson M J Immunol; 1981 Nov; 127(5):1734-9. PubMed ID: 6975295 [No Abstract] [Full Text] [Related]
9. Genetics, regulation, and specificity of murine natural antitumor antibodies and natural killer cells. Chow DA; Wolosin LB; Greenberg AH J Natl Cancer Inst; 1981 Aug; 67(2):445-53. PubMed ID: 6943381 [TBL] [Abstract][Full Text] [Related]
10. Modulation of sensitivity to natural killer cell lysis after in vitro explantation of a mouse lymphoma. Becker S; Kiessling R; Lee N; Klein G J Natl Cancer Inst; 1978 Dec; 61(6):1495-8. PubMed ID: 281556 [TBL] [Abstract][Full Text] [Related]
11. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers. Kaminsky SG; Nakamura I; Cudkowicz G J Immunol; 1983 Apr; 130(4):1980-4. PubMed ID: 6833756 [TBL] [Abstract][Full Text] [Related]
12. Genetic control of the natural killer cell activity in SJL and other strains of mice. Kaminsky SG; Nakamura I; Cudkowicz G J Immunol; 1985 Jul; 135(1):665-71. PubMed ID: 3923115 [TBL] [Abstract][Full Text] [Related]
13. Immunization of mice with syngeneic Moloney lymphoma cells induces separate antibodies against virion envelope glycoprotein and virus-induced cell surface antigens. Fenyo EM; Yefenof E; Klein E; Klein G J Exp Med; 1977 Dec; 146(6):1521-33. PubMed ID: 925612 [TBL] [Abstract][Full Text] [Related]
14. [Experimental analysis of intracerebral natural resistance against H-2+ and H-2- lymphomas grafted into the brain]. Yamasaki T; Kikuchi H; Yamashita J; Ljunggren HG; Karre K; Klein G No Shinkei Geka; 1989 Aug; 17(8):717-23. PubMed ID: 2586713 [TBL] [Abstract][Full Text] [Related]
15. Genes of the H-2 complex regulate the antibody response to murine leukemia virus. Vlug A; Schoenmakers HJ; Melief CJ J Immunol; 1981 Jun; 126(6):2355-60. PubMed ID: 6262410 [TBL] [Abstract][Full Text] [Related]
16. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants. Bishop GA; Marlin SD; Schwartz SA; Glorioso JC J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157 [TBL] [Abstract][Full Text] [Related]
17. Serologic analysis of tumor-associated surface antigens on a Moloney leukemia virus-induced lymphoma, MBL-2. Ng AK; McIntire R; Holden HT; Herberman RB J Immunol; 1978 Sep; 121(3):856-62. PubMed ID: 690439 [No Abstract] [Full Text] [Related]
18. Immune responses to weakly immunogenic virally induced tumors. III. Genetically unrestricted cytolysis of allogeneic tumor target cells. Devens B; Naor D J Immunol; 1979 Apr; 122(4):1397-401. PubMed ID: 312839 [TBL] [Abstract][Full Text] [Related]
19. Separation of the Moloney leukemia virus-determined cell surface antigen (MCSA) from known virion proteins associated with the cell membrane. Siegert W; Fenyö EM; Klein G Int J Cancer; 1977 Jul; 20(1):75-82. PubMed ID: 71277 [TBL] [Abstract][Full Text] [Related]
20. Sex and H-2 haplotype control the resistance of CBA-BALB hybrids to the induction of T cell lymphoma by Moloney leukemia virus. Storch TG; Chused TM J Immunol; 1984 Nov; 133(5):2797-800. PubMed ID: 6332861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]